Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
评级/大行评级
111评级/大行评级最新消息,评级/大行评级最新报道
News Articles
-
“彻底失望”!德银首次下调诺和诺德评级
诺和诺德关键减肥药CagriSema临床不及礼来,引发罕见降级潮:德银五年来首降评级,摩根大通下调至“中性”并砍销售预期63%。股价周一暴跌16%,目前仅37%分析师给予“买入”评级。市场焦点转向ziltivekimab三期数据,或成关键催化剂。
Newsflash
No data
Cryptocurrency
No data
Recommended Reading




